William Mack & Associates
PFE icon

William Mack & Associates’s Pfizer PFE Stock Holding History

William Mack & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$44.4K Buy
+1,556
New +$41.4K 0.01% 258

Other funds holding PFE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

William Mack & Associates's PFE Position: Q3 2026 in Review

William Mack & Associates opened a new position in Pfizer (PFE) in Q3 2026: 1,556 shares worth $44.4K. The stake represents 0.01% of the portfolio and ranks #258 among its holdings.

2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • William Mack & Associates held 1,556 shares of Pfizer worth $44.4K as of Q3 2026.
  • Pfizer was a new William Mack & Associates position in Q3 2026.
  • Pfizer made up 0.01% of William Mack & Associates's portfolio in Q3 2026, its #258 holding.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.